Influence of hormone therapy on the development of breast cancer in transgender women: A literature review
DOI:
https://doi.org/10.33448/rsd-v13i1.44701Keywords:
Breast cancer; Transsexual woman; Hormone replacement therapy.Abstract
Objective: The present study aims to correlate hormonal therapy with the development of breast cancer in transsexual women, as well as describe the findings of hormonal therapy in transsexual women correlating with the possible development of breast cancer. Methods: Integrative Literature Review of a descriptive nature. For analysis of data on cases of breast cancer in transgender women and the possible influence of hormonal therapy. When 6 articles were selected, they were carefully analyzed in a qualitative and quantitative manner. Results: Transsexual women who are seeking a feminization process are at risk of developing breast cancer, due to increased levels of estrogen in the circulation. Therefore, the risk of developing breast malignancy in transgender women is 47 times greater than in cisgender men, however, this risk is reduced compared to cisgender women. Trans women have fewer mammograms than cisgender women. Conclusion: The relationship is still not clear when compared to cisgender women. There are reports that indicate a correlation between exposure above physiological levels of estrogen and breast cancer, but some authors defend the thesis that the trans population would not be exposed to hormones for a long enough period of time for the development of malignant neoplasia.
References
Adorno, T. L., et al. (2021). Influência da hormonioterapia na incidência de câncer em transexuais. Brazilian Journal of Development 7(6), 56017-56039.
Alves, P., Mendonça, N., & Mendonça, W. (2022). Rastreio de câncer de mama em transgêneros: uma revisão integrativa de literatura. Research, Society and Development 11(17), 1-9.
Melo, V., Pinto, J., & Silva L. C. (2022). Terapia hormonal em mulher transexual idosa: um estudo de caso. Research, Society and Development 11(10), 1-11.
Alves N., Caminha M., Feitosa K., & Mendes M. (2017). Complicações na gestação em mulheres com idade maior ou igual a 35 anos.Rev Gaúcha Enferm,38(4),2017-0042.
Theodoro J. (2020). O que é transexual? Significados. https://www.significados.com.br/transexual/
Bardin, L. (1997). Análise de conteúdo. Edições 70.
Franco, M. (2008). A análise de conteúdo. Brasília: Líber Livro.
Coelho, M. T. Á .D.; & Sampaio, L .L. P. (2012). Transsexuality: psychological characteristics and new demands on the healthcare sector. Interface - Comunic., Saúde, Educ., 16(42) 637-49.
Costa, E. et al. (2020). Medicina Diagnóstica Inclusiva: Cuidando de Pacientes Transgêneros. Posicionamento Conjunto. https://www.endocrino.org.br/media/pdfs_documentos/posicionamento_trangenero_sbem_sbpcml_cbr.p df.
Corso, G., Gandini, S., Oriana D’Ecclesiis, Mazza, M., Magnoni, F., Veronesi, P., Galimberti, V., & Carlo La Vecchia. (2023). Risk and incidence of breast cancer in transgender individuals: a systematic review and meta-analysis. European Journal of Cancer Prevention, 32(3), 207–214. https://doi.org/10.1097/cej.0000000000000784
Joint, R., Zhong Eric Chen, & Cameron, S. (2018). Breast and reproductive cancers in the transgender population: a systematic review. Bjog: An International Journal of Obstetrics and Gynaecology, 125(12), 1505–1512. https://doi.org/10.1111/1471-0528.15258
Castro, A. D., & Nagelberg, A. (2019). Screening mamario en pacientes transgénero bajo tratamiento hormonal cruzado (thc): Situación actual y controversias. Revista Argentina de Mastología, 38(137), 116-32.
Alves, A. & Santos, I. (2022). Papel do farmacêutico na hormônio terapia de mulheres transgênero. Centro de informações sobre medicamentos. https://www.crfmg.org.br/site/uploads/areaTecnica/20221109[085941]Nota_Tecnica_002-22_Papel_do_farmaceutico_na_hormonioterapia_de_mulheres_Transgenero.pdf.
Cameron, S., Chen, Z., & Joint, R. (2018). Breast and reproductive cancers in the transgender population: a systematic review. Obstet. Gynaecol., 125(12) 1505–12.
Cohen-Kettenis, P., Delemarre-van, Gooren, L., Hembree, W., Meyer, W., Spack, N. et al. (2009). Endocrine Treatment of Transsexual Persons: An Endocrine Society Clinical Practice Guideline. Endocrinol. Metab., 94(9) 3132–54.
Filho, G. B. (2021). Bogliolo - Patologia. Grupo GEN, (9a ed.).
Instituto nacional de câncer, INCA (2022). Eu cuido da minha saúde todo dia, e você? https://www.inca.gov.br/campanhas/outubro-rosa/2022/eu-cuido-da-minha-saude-todos-os-dias-e-voce#:~:text=O%20c%C3%A2ncer%20de%20mama,-O%20c%C3%A2ncer%20de&text=As%20taxas%20de%20incid%C3%AAncia%20variam,a%20cada%20100%20mil%20mulheres.
Calas, M J. (2022). Câncer de mama em transexuais provoca alerta sobre prevenção. Oncoguia. http://www.oncoguia.org.br/conteudo/cancer-de-mama-em-transexuais-provoca-alerta-sobre-prevencao/15805/7/#:~:text=Segundo%20uma%20pesquisa%20realizada%20em,g%C3%AAnero%20correspondendente%20ao%20sexo%20biol%C3%B3gico.
Porto, C. C. (2019). Semiologia médica (8a ed.). Grupo GEN. 881-896.
Kiran, T., et al. (2019). Cancer screening rates among transgender adults: Cross-sectional analysis of primary care data. Canadian family physician Medecin de famille canadien, 65 (1), 30-37. https://www.cfp.ca/content/65/1/e30.long.
Equipe oncoguia (2020). Câncer de mama receptor de hormônio. http://www.oncoguia.org.br/conteudo/cancer-de-mama-receptor-de-hormonio/10879/264/
Equipe oncoguia (2022). Câncer de mama em homens. http://www.oncoguia.org.br/conteudo/cancer-de-mama-em-homens/15752/7/#:~:text=O%20c%C3%A2ncer%20de%20mama%20em,especialmente%20a%20do%20gene%20BRCA2.
Davidson, N., & Yager, J. (2006). Estrogen Carcinogenesis in Breast Cancer. N. Engl. J. Med. 354(3) 270–282.
Key, T., & Travis, R. (2003). Oestrogen exposure and breast cancer risk. Breast Cancer Res. 5 (5) 239–47.
Gompel, A (2019). Hormones et cancers du sein. Presse Med. 48(10) 1085–91.
Hartley, R., Stone, J. P., & Temple-Oberle, C. (2018). Breast cancer in transgender patients: A systematic review. Part 1: Male to female. Ejso, 44(10), 1455–1462. https://doi.org/10.1016/j.ejso.2018.06.035
Santen, R., et al. (2012). Modeling of the growth kinetics of occult breast
tumors: Role in interpretation of studies of prevention and menopausal hormone therapy. Cancer Epidemiol. Biomarkers Prev. 21(7) 1038–48.
Sonnenblick, E. B., et al. (2018). Breast Imaging of Transgender Individuals: A Review. Current radiology reports. 6(1) 1.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Júlia Luna Nascimento ; Rodrigo Félix de Oliveira Lúcio; Wanderliza Laranjeira Coutinho; Laís Lobo Coimbra Brandão Sá
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
